Sanford Guide to Antimicrobial Therapy 2020

Pocket edition

Referenz

Kitteltaschenbuch

David N. Gilbert (Herausgeber)

Buch | Softcover

2020 | 50. Auflage
Antimicrobial Therapy Inc. (Verlag)
978-1-944272-13-5 (ISBN)

Titel erscheint in neuer Auflage

Artikel merken

Zu diesem Artikel existiert eine Nachauflage

Sanford Guide to Antimicrobial Therapy 2021

David N. Gilbert

2021, 51. Auflage

Buch | Softcover

34, ⁹⁰ €

zur Neuauflage

The 50th edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information.

Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The »Sanford Guide« provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable.

Coverage includes:

Clinical syndromes
- pathogens
- bacterial
- fungal
- mycobacterial
- parasitic
- viral
Anti-infective agents
- dosing
  - pediatric adjustments
  - renal adjustments
- adverse affects
- activity
- pharmacology
- interactions
Preventative therapy

What's new in 2020:

Table 1: Osteomyelitis, meningitis, amnionitis, gastric ulcer, traveler’s diarrhea, C. difficile, keratitis, epididymo-orchitis, septic arthritis, prosthetic joint infection, pneumonia (empiric: age-determined, CAP, HAP, VAP; and specific, esp. GNB); secondary peritonitis, pharyngitis, parapharyngeal space infection, ulcerated skin, bacillary angiomatosis, thrombophlebitis
Table 2: Updated treatment options overview, especially gram-negative bacilli
Table 3: Duration of therapy: bacteremia, bone, genital, intra-abdominal, kidney
Table 4: New drugs and updates reflecting shifting susceptibility/resistance patterns
Table 5: Highly resistant bacteria, especially GNB
Table 6: MRSA
Table 7: New desensitization protocols
Table 8: Pregnancy risk & lactation safety for new drugs
Table 9: PK & interactions data for new drugs
Table 10: New antibacterials, including cefidericol, imipenem-cilastatin-relebactam, lefamulin and drug information for agents available in other regions, e.g., IV forsfomycin
Table 11: Updated recommendations, including Candida auris
Table 12: Updated recommendations for MDR tuberculosis and non-tuberculous mycobacteria
Table 13: Updated recommendations and drug availability for intestinal protozoa, malaria, trypanosomiasis, worms
Table 14: Adenovirus, coronavirus (2019-nCoV), Ebola, Epstein-Barr virus, neonatal herpes, influenza, measles; HIV – new ARVs
Table 15: Surgical prophylaxis
Table 16: Updated pediatric dosing for new and older drugs
Table 17: Renal impairment adjustments for new and some older drugs; updated obesity dosing
Table 22: Drug-drug interactions updates for new and existing antimicrobials

Erscheinungsdatum	19.06.2020
Sprache	englisch
Einbandart	kartoniert
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
Themenwelt	Studium ► Querschnittsbereiche ► Infektiologie / Immunologie
Schlagworte	Antibiotika • Antibiotika-Dosierung • Antibiotika-Resistenz • Antibiotikatherapie • Antiinfektiva • Antimikrobiell • Antimikrobieller Wirkstoff • Bakterielle Infektionen • Coronavirus • Infektionskrankheiten Antibiotika • Mykologie • Parasitolgie • SARS-CoV-19 • Viruserkrankungen
ISBN-10	1-944272-13-5 / 1944272135
ISBN-13	978-1-944272-13-5 / 9781944272135
Zustand	Neuware